GNS Stock Overview
Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Genus plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£20.95 |
| 52 Week High | UK£21.60 |
| 52 Week Low | UK£14.24 |
| Beta | 0.58 |
| 1 Month Change | 29.48% |
| 3 Month Change | 17.96% |
| 1 Year Change | 11.91% |
| 3 Year Change | -21.59% |
| 5 Year Change | -37.83% |
| Change since IPO | 1,451.85% |
Recent News & Updates
Genus plc (LON:GNS) Stock Catapults 36% Though Its Price And Business Still Lag The Industry
May 10
An Intrinsic Calculation For Genus plc (LON:GNS) Suggests It's 21% Undervalued
Apr 18Recent updates
Genus plc (LON:GNS) Stock Catapults 36% Though Its Price And Business Still Lag The Industry
May 10An Intrinsic Calculation For Genus plc (LON:GNS) Suggests It's 21% Undervalued
Apr 18
Regulatory Approvals And Sustainability Initiatives Will Strengthen Future Market Position
Expansion in the porcine business and PRRS resistant pig commercialization boosts revenue stability and growth through innovation and market penetration.There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise
Feb 01Lacklustre Performance Is Driving Genus plc's (LON:GNS) Low P/S
Nov 20Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217
Oct 23There May Be Some Bright Spots In Genus' (LON:GNS) Earnings
Oct 22Genus plc Just Missed EPS By 72%: Here's What Analysts Think Will Happen Next
Sep 08The Price Is Right For Genus plc (LON:GNS)
Jun 16Estimating The Fair Value Of Genus plc (LON:GNS)
Apr 20Is Genus (LON:GNS) Using Too Much Debt?
Mar 25With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For
Mar 05Genus (LON:GNS) Has Affirmed Its Dividend Of £0.103
Feb 25Getting In Cheap On Genus plc (LON:GNS) Might Be Difficult
Jan 17Does This Valuation Of Genus plc (LON:GNS) Imply Investors Are Overpaying?
Dec 10We Think Genus (LON:GNS) Is Taking Some Risk With Its Debt
Nov 03Calculating The Intrinsic Value Of Genus plc (LON:GNS)
Sep 09Is Genus (LON:GNS) A Risky Investment?
Mar 29Is Genus (LON:GNS) Using Too Much Debt?
Dec 21It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year
Nov 17Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217
Oct 25Genus (LON:GNS) Is Paying Out A Dividend Of £0.217
Oct 11Genus' (LON:GNS) Dividend Will Be £0.217
Sep 11A Look At The Fair Value Of Genus plc (LON:GNS)
Sep 09A Look At The Intrinsic Value Of Genus plc (LON:GNS)
May 31Is Genus (LON:GNS) A Risky Investment?
Mar 29Genus (LON:GNS) Has Re-Affirmed Its Dividend Of UK£0.10
Feb 27Is Genus plc (LON:GNS) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 22With EPS Growth And More, Genus (LON:GNS) Is Interesting
Oct 29Shareholder Returns
| GNS | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | 2.2% | -0.4% | 1.1% |
| 1Y | 11.9% | -14.8% | 0.8% |
Return vs Industry: GNS exceeded the UK Biotechs industry which returned -14.8% over the past year.
Return vs Market: GNS exceeded the UK Market which returned 0.8% over the past year.
Price Volatility
| GNS volatility | |
|---|---|
| GNS Average Weekly Movement | 8.1% |
| Biotechs Industry Average Movement | 9.2% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 3.2% |
Stable Share Price: GNS's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: GNS's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 3,500 | JK Kokke | www.genusplc.com |
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Genus plc Fundamentals Summary
| GNS fundamental statistics | |
|---|---|
| Market cap | UK£1.38b |
| Earnings (TTM) | -UK£4.00m |
| Revenue (TTM) | UK£671.60m |
Is GNS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GNS income statement (TTM) | |
|---|---|
| Revenue | UK£671.60m |
| Cost of Revenue | UK£413.50m |
| Gross Profit | UK£258.10m |
| Other Expenses | UK£262.10m |
| Earnings | -UK£4.00m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Sep 04, 2025
| Earnings per share (EPS) | -0.061 |
| Gross Margin | 38.43% |
| Net Profit Margin | -0.60% |
| Debt/Equity Ratio | 48.1% |
How did GNS perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/20 23:40 |
| End of Day Share Price | 2025/05/20 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Genus plc is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Chantry | Berenberg |
| Alexander Jones | BofA Global Research |
| Matthew John Yates | BofA Global Research |